Please use this identifier to cite or link to this item:
Title: Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona.
Author: Coll, Pere
Aragón, Lina Marcela
Alcaide Fernández de Vega, Fernando
Espasa, Mateo
Garrigó, Montserrat
González Martín, Julián
Manterola, Jose M.
Orús, Pilar
Salvadó, Margarita
Keywords: Mycobacterium tuberculosis
Medicaments antituberculosos
Resistència als medicaments
Genètica molecular
Mycobacterium tuberculosis
Antitubercular agents
Drug resistance
Molecular genetics
Issue Date: 23-May-2005
Publisher: Mary Ann Liebert, Inc.
Abstract: We studied the presence of mutations in the whole katG gene and specific regions of the oxyR-ahpC and mabA-inhA regulatory region in 61 Mycobacterium tuberculosis isoniazid-resistant isolates. An 81-bp region of the rpoB gene was also sequenced in 17 rifampin-resistant strains. Alterations in the katG gene were detected in 55% of the isolates. Mutation in codon 315 was the most prevalent (32%). Strains showed a high level of resistance, and most maintained a substantial catalase-peroxidase activity. Three strains with an isoniazid MIC of ≥32 µg/ml lacked catalase-peroxidase activity. Two of them had deletions in the catalytic domain of the KatG protein. One strain with deletion and three strains with mutations in the C-terminal domain showed low-level resistance and conserved the catalase-peroxidase activity. Mutations in the mabA-inhA regulatory region were identified in 32% of the isolates. All had low-level resistance, and the vast majority conserved catalase-peroxidase activity. Seventeen percent of the isoniazid-resistant isolates had no detectable alterations at the studied loci. Resistance to rifampin was associated with mutations in the 81-bp of the rpoB gene in all cases. IS6110 analysis indicated that recent transmission contributed substantially to the emergence of isoniazid- resistant tuberculosis in Barcelona through short transmission chains. A rapid genotypic assay, including the 315-katG codon and the -15 nucleotide of the mabA-inhA regulatory region, may cover 62% of isoniazid- resistant strains in Barcelona. In contrast, the targeting of the 81-bp region of rpoB would detect all our rifampin-resistant isolates.
Note: Reproducció del document publicat a:
It is part of: Microbial Drug Resistance, 2005, vol. 11, num. 2, p. 107-114
Related resource:
ISSN: 1076-6294
Appears in Collections:Articles publicats en revistes (Fonaments Clínics)

Files in This Item:
File Description SizeFormat 
639143.pdf89.44 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.